STAT

Opinion: The time is now to take a shot at eliminating six cancers caused by HPV

Source: Joe Raedle/Getty Images

If you had the power to eliminate several common cancers and prevent your children from developing them, you’d use it, wouldn’t you? We have that power today for cancers caused by the human papillomavirus (HPV), but we aren’t fully using our available resources, including vaccination for primary prevention and screening and treatment for precancerous changes in the cervix.

HPV causes six different kinds of cancer: cervical, oropharyngeal (throat), anal, penile, vaginal, and vulvar cancers. Shockingly, most of them are. Our best prevention tool — the HPV vaccine — hasn’t been fully utilized. , the last year for which full data are available, only 53% of eligible girls and 44% of eligible boys in the United States received the HPV vaccine. Part of the reason is that not everyone has learned what the vaccine can do. Another part is that some parents misunderstand it. We have an educational challenge. Some would say the vaccine has an image problem.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks